Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Nov 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1124105
- Fiscal year ends
- December
- Filer status
- Accelerated filer, Smaller reporting company
Financials 8 of 56
News 8 of 220
- 8-K Quarterly results Nov 5, 2026
- 8-K Leadership change Oct 22, 2026
- 8-K Current report on a material event Sep 1, 2026
- 8-K Current report on a material event Aug 26, 2026
- 8-K Quarterly results Aug 7, 2026
- 8-K Leadership change Jul 16, 2026
- 8-K/A Quarterly results Jul 15, 2026
- 8-K Shareholder vote results Jun 16, 2026
Prospectuses and Registrations 8 of 55
- S-8 Registration statement for an employee plan Aug 27, 2026
- S-3/A Shelf registration statement, amended Jul 13, 2026
- S-3 Shelf registration statement Jun 23, 2026
- S-8 Registration statement for an employee plan Jun 10, 2026
- 424B5 Prospectus supplement for an offering May 23, 2025
- 424B5 Prospectus supplement for an offering May 22, 2025
- S-8 Registration statement for an employee plan Mar 20, 2025
- 424B5 Prospectus supplement for an offering Nov 27, 2024
Proxies 8 of 43
- DEFA14A Extra proxy material May 4, 2026
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 16, 2026
- DEFA14A Extra proxy material Apr 21, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
Ownership 8 of 537
- 4 Insider reported a trade Aug 4, 2026
- 4 Insider reported a trade Aug 4, 2026
- 3 Insider reported their initial holding Aug 4, 2026
- 3 Insider reported their initial holding Aug 4, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 30, 2026
Other 8 of 90
- EFFECT Notice that a registration became effective Aug 3, 2026
- ARS Annual report sent to shareholders Apr 27, 2026
- ARS Annual report sent to shareholders Apr 22, 2025
- EFFECT Notice that a registration became effective Nov 22, 2024
- CORRESP Reply to SEC staff Nov 20, 2024
- UPLOAD Comment letter from SEC staff Nov 20, 2024
- RW Jul 12, 2024
- RW Jul 12, 2024
Everything here comes from Gyre Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.